hepatitis-c

Documents about hepatitis-c

• Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China#847785ClinicalTrials.gov
• Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048)#848638ClinicalTrials.gov
• Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C#853730ClinicalTrials.gov
• Monitoring Liver Disease Progression in Hepatitis C/HIV Co-infected Patients With No-to-moderate Fibrosis, in Phnom Penh, Cambodia#856560ClinicalTrials.gov
• Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin#861332ClinicalTrials.gov
• An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Ribavirin Based Regimens in Patients With Chronic Hepatitis C With Previous Treatment Failure#879026ClinicalTrials.gov
• Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044)#884523ClinicalTrials.gov
• Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients#889995ClinicalTrials.gov
• Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523)#906993ClinicalTrials.gov
• Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis C#908027ClinicalTrials.gov
• ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings#911946ClinicalTrials.gov
• Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting#917189ClinicalTrials.gov
• Fabrication and Development of a Microfluidic Paper-Based Immunosorbent Assay Platform (μpisa) for Colorimetric Detection of Hepatitis C#1027218İzmir Yüksek Teknoloji Enstitüsü
• Investigation of changes in irisin and nesfatin-1 levels in chronic viral hepatitis#446720Recep Tayyip Erdoğan University Institutional Repository
• Incidence of hepatitis C virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: increasing rates of HCV diagnosis but not of HCV seroconversions#210695Dipòsit Digital de la Universitat de Barcelona
• Increasing competition in pharmaceutical tenders: Patents, treatment guidelines, and centralised procurement of Hepatitis C drugs in Brazil.#400691PubMed
• DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral)#836732ClinicalTrials.gov
• Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM3)(COMPLETED)#846728ClinicalTrials.gov
• Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients.#849697ClinicalTrials.gov
• Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)#862021ClinicalTrials.gov
• BMS-790052 (Daclatasvir) Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C#868090ClinicalTrials.gov
• Lifestyle Intervention Targetting Obesity and Insulin Resistance in Chronic Hepatitis C#875032ClinicalTrials.gov
• Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis C#877531ClinicalTrials.gov
• A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients#894575ClinicalTrials.gov
• Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C#902212ClinicalTrials.gov
• A Community-based Intervention Among Active Drug Users in Montpellier#902342ClinicalTrials.gov
• PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1 (Study P04511)(COMPLETED)#992057ClinicalTrials.gov
• Health Behavior Feedback Study for Veterans With Hepatitis C#1010226ClinicalTrials.gov
• Nationwide seroprevalence study of hepatitis B and hepatitis C viruses among blood donors in Paraguay.#309124NCBI PubMed Central
• GUM Remote Testing v4.0#827879ClinicalTrials.gov
• Sonazoid Enhanced Liver Cancer Trial for Early Detection#993727ClinicalTrials.gov
• Efficacy and safety of direct-acting antivirals in patients with hepatitis c infection: nationwide real-life data from türkiye#269685Recep Tayyip Erdoğan University Institutional Repository
• Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults#825985ClinicalTrials.gov
• The Pharmacokinetics of P1101 + Ribavirin in Interferon Treatment-Naïve Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection#828458ClinicalTrials.gov
• Study to Assess the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ABT-267 in HCV Infected Subjects#830802ClinicalTrials.gov
• CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)#854736ClinicalTrials.gov
• Effects of Sho-saiko-to, a Herbal Formula, in Reducing Viral Load in Hepatitis C#866691ClinicalTrials.gov
• A Study of RO5190591 (Danoprevir) in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 Virus Infection#901612ClinicalTrials.gov
• Impact of the Sustained Viral Response of Chronic Hepatitis c After Treatment With Direct Action Antivirals#908527ClinicalTrials.gov
• A Self-efficAcy Intervention to reDuce Injecting Risk behAviour and hePatitis c reinfecTion Rates#913046ClinicalTrials.gov
• A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC).#980556ClinicalTrials.gov
• Liver Test Study of Using JKB-122 in Hepatitis C Virus (HCV)-Positive Patients Nonresponsive to Prior Interferon Based Therapies#981380ClinicalTrials.gov
• Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin Resistance#886058ClinicalTrials.gov
• Patient-Centered Care and Asian Americans#994414ClinicalTrials.gov
• Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection#889282ClinicalTrials.gov
• Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)#906228ClinicalTrials.gov
• Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant#850972ClinicalTrials.gov
• A Study of Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6#812354ClinicalTrials.gov
• The Patient-Reported Outcomes Project of HCV-TARGET#825127ClinicalTrials.gov
• Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population#827256ClinicalTrials.gov